SEARCH

SEARCH BY CITATION

References

  • 1
    Fuda, N. J., Ardehali, M. B., and Lis, J. T. ( 2009) Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461, 186192.
  • 2
    Pan, Y., Tsai, C. J., Ma, B., and Nussinov, R. ( 2009) How do transcription factors select specific binding sites in the genome? Nat. Struct. Mol. Biol. 16, 11181120.
  • 3
    Pan, Y., Tsai, C. J., Ma, B., and Nussinov, R. ( 2010) Mechanisms of transcription factor selectivity. Trends Genet. 26, 7583.
  • 4
    Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R., and Young, R. A. ( 2007) A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 7788.
  • 5
    Forsberg, E. C., Johnson, K., Zaboikina, T. N., Mosser, E. A., and Bresnick, E. H. ( 1999) Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region. J. Biol. Chem. 274, 2685026859.
  • 6
    McKenna, N. J., Lanz, R. B., and O'Malley, B. W. ( 1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321344.
  • 7
    Li, Q., Peterson, K. R., Fang, X., and Stamatoyannopoulos, G. ( 2002) Locus control regions. Blood 100, 30773086.
  • 8
    Naar, A. M., Lemon, B. D., and Tjian, R. ( 2001) Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475501.
  • 9
    Gao, X., Loggie, B. W., and Nawaz, Z. ( 2002) The roles of sex steroid receptor coregulators in cancer. Mol. Cancer 1, 7.
  • 10
    Perissi, V., Aggarwal, A., Glass, C. K., Rose, D. W., and Rosenfeld, M. G. ( 2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116, 511526.
  • 11
    Lonard, D. M., and O'Malley B, W. ( 2007) Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27, 691700.
  • 12
    Carson-Jurica, M. A., Schrader, W. T., and O'Malley, B. W. ( 1990) Steroid receptor family: structure and functions. Endocr. Rev. 11, 201220.
  • 13
    Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., et al. ( 1995) The nuclear receptor superfamily: the second decade. Cell 83, 835839.
  • 14
    Novac, N. and Heinzel, T. ( 2004) Nuclear receptors: overview and classification. Curr. Drug Targets Inflamm. Allergy 3, 335346.
  • 15
    Sommer, S. and Fuqua, S. A. ( 2001) Estrogen receptor and breast cancer. Semin. Cancer Biol. 11, 339352.
  • 16
    Bai, Z. and Gust, R. ( 2009) Breast cancer, estrogen receptor and ligands. Arch. Pharm. (Weinheim) 342, 133149.
  • 17
    Dahlman-Wright, K., Cavailles, V., Fuqua, S. A., Jordan, V. C., Katzenellenbogen, J. A., et al. ( 2006) International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol. Rev. 58, 773781.
  • 18
    McKenna, N. J. and O'Malley, B. W. ( 2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465474.
  • 19
    York, B. and O'Malley, B. W. ( 2010) Steroid receptor coactivator (SRC) family: masters of systems biology. J. Biol. Chem. 285, 3874338750.
  • 20
    Chen, H. I. and Sudol, M. ( 1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA 92, 78197823.
  • 21
    Sudol, M., Chen, H. I., Bougeret, C., Einbond, A., and Bork, P. ( 1995) Characterization of a novel protein-binding module—the WW domain. FEBS Lett. 369, 6771.
  • 22
    Komuro, A., Nagai, M., Navin, N. E., and Sudol, M. ( 2003) WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278, 3333433341.
  • 23
    Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., et al. ( 2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. USA 103, 1240512410.
  • 24
    McDonald, C. B., McIntosh, S. K., Mikles, D. C., Bhat, V., Deegan, B. J., et al. ( 2011) Biophysical analysis of binding of WW domains of the YAP2 transcriptional regulator to PPXY motifs within WBP1 and WBP2 adaptors. Biochemistry 50, 96169627.
  • 25
    Sudol, M. ( 1996) Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65, 113132.
  • 26
    Sudol, M. and Hunter, T. ( 2000) NeW wrinkles for an old domain. Cell 103, 10011004.
  • 27
    Wang, K., Degerny, C., Xu, M., and Yang, X. J. ( 2009) YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem. Cell Biol. 87, 7791.
  • 28
    Harvey, K. and Tapon, N. ( 2007) The Salvador-Warts-Hippo pathway—an emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182191.
  • 29
    Ludes-Meyers, J. H., Kil, H., Bednarek, A. K., Drake, J., Bedford, M. T., et al. ( 2004) WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene 23, 50495055.
  • 30
    Bednarek, A. K., Laflin, K. J., Daniel, R. L., Liao, Q., Hawkins, K. A., et al. ( 2000) WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60, 21402145.
  • 31
    Del Mare, S., Kurek, K. C., Stein, G. S., Lian, J. B., and Aqeilan, R. I. ( 2011) Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma. Am. J. Cancer Res. 1, 585594.
  • 32
    Jolliffe, C. N., Harvey, K. F., Haines, B. P., Parasivam, G., and Kumar, S. ( 2000) Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. Biochem. J. 351 ( pt 3), 557565.
  • 33
    Nitsch, R., Di Palma, T., Mascia, A., and Zannini, M. ( 2004) WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8. Biochem. J. 377, 553560.
  • 34
    Dhananjayan, S. C., Ramamoorthy, S., Khan, O. Y., Ismail, A., Sun, J., et al. ( 2006) WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors. Mol. Endocrinol. 20, 23432354.
  • 35
    Zhang, X., Milton, C. C., Poon, C. L., Hong, W., and Harvey, K. F. ( 2011) Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ. 18, 13461355.
  • 36
    Chan, S. W., Lim, C. J., Huang, C., Chong, Y. F., Gunaratne, H. J., et al. ( 2011) WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30, 600610.
  • 37
    Pfaffl, M. W. ( 2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
  • 38
    Catoe, H. W. and Nawaz, Z. ( 2011) E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76, 897902.
  • 39
    Lacroix, M. and Leclercq, G. ( 2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83, 249289.
  • 40
    Barkhem, T., Haldosen, L. A., Gustafsson, J. A., and Nilsson, S. ( 2002) pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element. Mol. Pharmacol. 61, 12731283.
  • 41
    Sun, J., Nawaz, Z., and Slingerland, J. M. ( 2007) Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol. Endocrinol. 21, 26512662.
  • 42
    Prange-Kiel, J., Rune, G. M., Zwirner, M., Wallwiener, D., and Kiesel, L. ( 2001) Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells. Exp. Clin. Endocrinol. Diabetes 109, 231237.
  • 43
    Metivier, R., Penot, G., Hubner, M. R., Reid, G., Brand, H., et al. ( 2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751763.
  • 44
    Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., et al. ( 2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell. 11, 695707.
  • 45
    Kim, M., Ahn, S. H., Krogan, N. J., Greenblatt, J. F., and Buratowski, S. ( 2004) Transitions in RNA polymerase II elongation complexes at the 3' ends of genes. EMBO J. 23, 354364.
  • 46
    Ahn, S. H., Kim, M., and Buratowski, S. ( 2004) Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. Mol. Cell 13, 6776.
  • 47
    Chen, J. and Li, Q. ( 2011) Life and death of transcriptional co-activator p 300. Epigenetics 6, 957961.
  • 48
    Schiltz, R. L., Mizzen, C. A., Vassilev, A., Cook, R. G., Allis, C. D., et al. ( 1999) Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274, 11891192.
  • 49
    Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., et al. ( 1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 11821189.
  • 50
    Leo, C. and Chen, J. D. ( 2000) The SRC family of nuclear receptor coactivators. Gene 245, 111.
  • 51
    Goodman, R. H. and Smolik, S. ( 2000) CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 15531577.
  • 52
    Kraus, W. L. and Kadonaga, J. T. ( 1998) p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12, 331342.
  • 53
    Chan, H. M. and La Thangue, N. B. ( 2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell. Sci. 114, 23632373.